topSkip to main content

Menu, Secondary

Menu Trigger

Menu

New York's Leading Public Research Universities on the Forefront of Education and Innovation

New York’s leading public research universities are on the forefront of education and scientific innovation.


Only sixty-five years young, Stony Brook University is recognized as one of the nation’s top research universities, serving as a powerful engine for economic development, technological innovation and clinical care. SBU is not only transforming lives by revolutionizing cancer prognosis and advancing life-saving technologies for cardiac patients but also by offering a world-class education to students from all socio-economic backgrounds, providing them unmatched social and economic mobility.

The University at Buffalo was recognized as a research powerhouse back in 1989, when it became the first public university in New York invited to join the AAU, and its impact has only grown over the years. From developing new ways to treat memory loss in Alzheimer’s to pioneering minimally invasive surgical techniques, UB is making discoveries that lead to longer, healthier lives.

Learn more about the amazing work happening every day at New York's flagship public research universities:

Physicians at the University at Buffalo performed their first surgery on a sleep apnea patient using a new, FDA-approved device which helps keep the airway open during sleep by controlling the muscle in the tongue.
New research shows that intermittent fasting can play a beneficial role in treating cancer by linking fat and protein-rich foods to increased incidence of cancer.
A review article by University at Buffalo researchers summarizes the latest technologies and methods guided by process systems engineering approaches, from chemical solvents that can dissolve specific plastics to automated plastic sorting aided by artificial intelligence.
NEJM study shows artery embolization cuts repeat brain surgeries for chronic subdural hematomas by two-thirds, transforming elderly patient care.

BUFFALO, N.Y. – A new molecule developed by University at Buffalo researchers acts like a local, long-lasting anesthetic, providing robust pain relief for up to three weeks, according to the results of preclinical studies reported recently in the journal Pain.